VideaHealth

Market position

Described in secondary sources as one of the leading dental AI platforms, with claimed use by 8 of the 10 largest North American DSOs and, per company materials, more than 90,000 clinicians. Named competitors in the dental AI segment are Overjet and Pearl. Note that figures vary across sources (for example, one source cites over 50,000 providers while company materials cite 90,000+ clinicians).

Sources attribute differentiation to the breadth of FDA-cleared detections (30+ conditions, including clearance for patients aged 3+), integration of diagnostics with documentation, patient communication and revenue-cycle workflows in a single platform, embedded distribution through practice-management software, and structured deployment programs that customers credit with driving adoption across locations.

Technology

Machine-learning models analyze dental radiographs to detect conditions such as caries, periapical lesions, calculus and bone loss, with secondary reporting citing FDA clearance across 30-plus detections and coverage of patients aged 3 and older. One source describes an internal "AI factory" process for rapidly iterating models annotated by high-performing clinicians. The platform layer adds automated charting and CDT coding, chairside patient-facing visuals, voice-based clinical documentation (Voice Notes, Voice Perio), enterprise dashboards and insights, and claims/eligibility automation (Clean Claims, AutoVerify).

Go-to-market

Sales are directed at dental support organizations and large dental groups, with a demo-request motion on the company website and case studies documenting structured rollouts and adoption frameworks across multi-location groups. Distribution partnerships are also cited, including a joint venture with Henry Schein One that embeds the AI in Dentrix practice-management software. As of the April 2026 rebrand, the company said it is extending its reach from large dental organizations to private practices.

Dental support organizations (DSOs), large multi-location dental groups, independent/private dental practices, and clinicians including dentists and hygienists; one source also cites dental insurers as users of claims-related tools.

Geography

Headquartered in the Boston/Cambridge, Massachusetts area (internal records list Cambridge; one source lists Boston, MA). Customers are described as being across North America, including the United States and Canada (DentalCorp).

History

Following a seed round in September 2019 and a $20 million Series A in March 2022 led by Spark Capital, the company raised a $40 million Series B announced on 28 January 2025 led by Emily Melton of Threshold Ventures. Secondary reporting describes a commercial launch in 2022 targeting large DSOs, FDA clearances covering 30-plus detections, and a 2024 joint venture with Henry Schein One integrating AI into Dentrix software (Dentrix Detect AI), alongside 2024 collaborations with Heartland Dental and DentalCorp. In April 2026 the company rebranded from VideaHealth to Videa and announced expansion from large dental organizations into private practices.

Risks & controversies

At the time of the March 2022 Series A, the company's Videa Detect X-ray software had not yet received FDA clearance and the company said it expected clearance in the coming months, indicating regulatory dependency. Source data is also inconsistent: reported clinician/provider counts, headquarters city, employee counts and investor lists differ between company materials and third-party aggregators, and several performance claims originate from the company's own marketing materials rather than independent verification.